Toxikon is a preclinical contract research organization. We contract and partner with biotech, pharmaceutical and medical device industries to deliver exceptional product development services from concept to final product.
Our FDA-registered and ISO 17025-accredited facilities in Bedford and Leuven, Belgium, are routinely inspected by these and other regulatory and international agencies, with positive outcomes that are available upon request from our clients. Toxikon is experienced in protocol preparation for IACUC and IRB submissions.
Our facilities meet all of the requirements of the federal and state laws pertaining to laboratory models under the AWA as enforced by the USDA, and our protocols and approval process are reviewed routinely by USDA, FDA, and equivalent European and Japanese regulatory agencies. Our facilities are also accredited by the Association for the Assessment and Accreditation of Laboratory and Animal Care (AAALAC).
Toxikon offers custom research and testing services in support of drug and device discovery and development. Our product development capabilities are focused on discoveries that improve the quality of life, while delivering quality science. Along with R&D/Discovery, these capabilities include ocular drug development, surgical programs, synthesis and formulation IND/NDA enabling studies, reproductive toxicology study designs, carcinogenicity, and full pathology capabilities. Working closely with our clients, we are committed to providing customized services that meet the required objectives of our clients' programs.